APELLIS PHARMACEUTICALS, INC.
Clinical trial NCT03531255 updates: 1. enrollment: 160 → 137 participants 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03531255 updates: 1. enrollment: 160 → 137 participants 2. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical